XBIT vs. XBIO

In the year-to-date period, XBIT achieves a -27.85% return, which is significantly lower than XBIO's -24.81% return. Over the past 10 years, XBIT has outperformed XBIO with an annualized return of -16.12%, while XBIO has yielded a comparatively lower -42.74% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for XBiotech Inc. (XBIT) and Xenetic Biosciences, Inc. (XBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current XBIT Sharpe Ratio is -0.77, which is lower than the XBIO Sharpe Ratio of -0.29. The chart below compares the historical Sharpe Ratios of XBIT and XBIO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither XBIT nor XBIO has paid dividends to shareholders.

The maximum XBIT drawdown since its inception was -92.67%, smaller than the maximum XBIO drawdown of -99.94%. Use the drawdown chart below to compare losses from any high point for XBIT and XBIO.

The current volatility for XBiotech Inc. (XBIT) is 12.20%, while Xenetic Biosciences, Inc. (XBIO) has a volatility of 13.89%. This indicates that XBIT experiences smaller price fluctuations and is considered to be less risky than XBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between XBiotech Inc. and Xenetic Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.